Mettler-Toledo International (NYSE:MTD) Given New $1,369.00 Price Target at Robert W. Baird

Mettler-Toledo International (NYSE:MTDFree Report) had its price objective lifted by Robert W. Baird from $1,362.00 to $1,369.00 in a research report report published on Monday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock.

A number of other equities research analysts have also issued reports on the stock. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their target price for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wells Fargo & Company dropped their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Wolfe Research assumed coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $1,368.00.

Check Out Our Latest Research Report on Mettler-Toledo International

Mettler-Toledo International Trading Down 3.6 %

NYSE:MTD opened at $1,339.46 on Monday. Mettler-Toledo International has a 1-year low of $1,133.46 and a 1-year high of $1,546.93. The firm has a market capitalization of $28.26 billion, a price-to-earnings ratio of 33.05, a PEG ratio of 4.80 and a beta of 1.13. The business’s fifty day moving average price is $1,278.92 and its 200 day moving average price is $1,342.95.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. Equities analysts forecast that Mettler-Toledo International will post 41.94 earnings per share for the current year.

Insider Activity

In other news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Hedge funds have recently added to or reduced their stakes in the business. Blue Trust Inc. increased its holdings in shares of Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC acquired a new position in Mettler-Toledo International in the 3rd quarter valued at approximately $37,000. SBI Securities Co. Ltd. bought a new stake in shares of Mettler-Toledo International in the 4th quarter worth approximately $33,000. Raleigh Capital Management Inc. grew its holdings in shares of Mettler-Toledo International by 272.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 30 shares in the last quarter. Finally, Whipplewood Advisors LLC bought a new stake in shares of Mettler-Toledo International during the fourth quarter valued at approximately $54,000. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

See Also

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.